Expanded access is a program that provides patients with investigational medicinal products (IMP) for treatment purposes. These patients are often excluded from clinical trials but could still benefit from access to the drugs, biologics or medical devices being tested. While, in concept, expanded access represents a way to help more patients receive new and developing treatments, in reality, the process is complex and often misunderstood.
Expanded Access: Past, Present and Future Improvements
Pharma IndustryRelated Articles
-
18 April 2017 The Innovator's Prescription -
18 April 2017 Why Brexit Happened and W... -
14 April 2017 Acting Decisively
